USGS

By Diane Barnes

Global Security Newswire

WASHINGTON -- The Obama administration on Wednesday said it is putting down $40 million on a first-of-its-kind plan for a major drug maker to pursue an assortment of experimental bioterrorism antibiotics, drawing from a single funding pool as it studies newly discovered formulations and abandons any found to show little promise.

The approach is more flexible than the government's traditional strategy of funding...